Clinical Validation of SMD-RVECG for Predicting Atrial Fibrillation With Rapid Ventricular Response Within 2 Hours

Conditions: Atrial Fibrillation (AF); Atrial Fibrillation With Rapid Ventricular Response

Interventions: Device: SMD-RVECG

Sponsors: HUINNO Co., Ltd; Seoul National University Hospital; Korea Medical Device Development Fund

Not yet recruiting